AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Study Measures Economic Benefits Of TB Vaccine.(Brief Article)
2002 JAN 9 - (NewsRx.com & NewsRx.net) -- The Sequella Global Tuberculosis Foundation (SGTBF) has announced the results of a study performed by David M. Bishai and Daniel Mercer of the Johns Hopkins University, whose work was supported by a grant from the SGTBF.
These results, as published in the International Journal of Tuberculosis and Lung Disease, suggest that at least a $1 billion return can be made on an investment in the development of an improved TB vaccine.
BCG vaccine, the current vaccine administered to children outside the U.S. at birth, has limited value in the prevention of adult pulmonary TB, although it is effective in reducing certain disseminated forms of TB in infants. The lack of an effective pulmonary TB vaccine has enormous global health consequences: TB is the leading single-agent infectious disease killer in the world today.
Since TB strikes people in the most productive years of their lives (15-45), it is also responsible for overwhelming poverty in communities with a high burden of this disease. Today, 2 billion people are infected with the causative agent of TB, there are more than 8 million new cases of TB each year, and two to three million people die of TB yearly.
An obstacle to the development of an improved TB vaccine is the widespread belief in the pharmaceutical industry and financial community that such a product will not yield a significant return on investment. ...
- Rockville-based tuberculosis foundation reports investment suggestion for...
- Newspaper article from: Daily Record (Baltimore, MD) December 18, 2001 700+ words
...Hopkins University suggests that at least a $1 billion return can be made on an investment in the development of an improved TB vaccine, according to the Rockville-based Sequella Global Tuberculosis Foundation, a nonprofit organization created...
- New TB Vaccine Due.
- Newspaper article from: New Vision (Uganda) March 29, 2006 700+ words
...2006 last week, Aeras Global TB Vaccine Foundation announced that they...produce the world's supply of an improved TB vaccine in the next seven years. This...foundation has four versions of a TB vaccine, which will be in phase 1 clinical...
- Aeras and Statens Serum Institut Enter Into Collaboration Agreement to Develop...
- Press release article from: PR Newswire March 30, 2005 700+ words
...towards the development of a new TB vaccine, which the world so desperately...of USD$82.9 million for new TB vaccine development. Aeras aims to work...organizations around the world to bring an improved TB vaccine to market within the next 7 to...
- AERAS/CRUCELL TO DEVELOP TB VACCINE.
- Newspaper article from: Worldwide Biotech May 1, 2004 700+ words
...Netherlands, and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland...of USD$82.9 million for new TB vaccine development. Aeras aims to work...organizations around the world to bring an improved TB vaccine to market within the next 7 to...
- Aeras partners with Crucell to develop TB vaccine.
- News wire article from: Europe Intelligence Wire March 24, 2004 700+ words
...CRXL) and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland...of USD$82.9 million for new TB vaccine development. Aeras aims to work...organizations around the world to bring an improved TB vaccine to market within the next 7 to...
- Medical economists estimate $1 billion return for adult pulmonary TB vaccine.
- Newspaper article from: Daily Record (Baltimore, MD) December 17, 2001 700+ words
...investment in the development of an improved TB vaccine. These results were published...possible economic benefits of a new TB vaccine, which include both decreases...The authors estimated that an improved TB vaccine could sell up to 1.17 billion...
- New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South...
- Press release article from: Business Wire April 22, 2009 700+ words
...TOWN, South Africa -- The Aeras Global TB Vaccine Foundation, the Oxford-Emergent Tuberculosis...concept clinical trial of a promising new TB vaccine developed at the University of Oxford...of-concept trial of a new preventive TB vaccine in infants in more than 80 years. ...
- GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner to...
- Press release article from: PR Newswire October 20, 2005 700+ words
...GSK Biologicals) and the Aeras Global TB Vaccine Foundation (Aeras) today announced...for developing a safe and effective TB vaccine," said Dr. Jerald Sadoff, CEO of the Aeras Global TB Vaccine Foundation. "Cooperation between the...
- Aeras Receives CDC Funding to Develop TB Vaccine Trial Sites in India; 3 year,...
- Press release article from: PR Newswire September 17, 2004 700+ words
...17 /PRNewswire/ -- Aeras Global TB Vaccine Foundation today announced a $925...the serious shortfall in international TB vaccine funding and will hasten the day when...early childhood. Although spending on TB vaccine research accounts for only a small fraction...
- Jerald Sadoff M.D. Named CEO of TB Vaccine Effort; Aeras Global TB Vaccine...
- Press release article from: PR Newswire September 17, 2003 700+ words
...17 /PRNewswire/ -- The Aeras Global TB Vaccine Foundation, formerly known as the Sequella...also announced a new scientific focus on TB vaccine development. This will leave the development...companies have been reluctant to invest in TB vaccine development because most of the need...
Source: HighBeam Research, Study Measures Economic Benefits Of TB Vaccine.(Brief Article)